PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 25 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

17 December 2025

  1. (diff | hist) m 10:33 Arcuate nucleus 5,251 ±0 SatietySunniva (talk | contribs) add category for receptor pharmacology [rollback]
  2. (diff | hist) 08:01 AmbioPharm 10,797 +971 DisparityDagny (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  3. (diff | hist) m b 06:14 Shanghai ERP Biotechnology 10,240 +592 CiteBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m 01:52 Drug master file 4,325 ±0 Chromatokid (talk | contribs) add the good-manufacturing-practice framework by name [rollback]

16 December 2025

  1. (diff | hist) m b 18:41 Tianjin Finder Chemical 14,449 +480 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) 16:06 Peptide 6,813 ±0 ParentCatPansy (talk | contribs) de-duplicate a repeated sentence [rollback]

15 December 2025

  1. (diff | hist) 23:30 Baseline laboratory panel 4,429 ±0 LipidLedgerLou (talk | contribs) correct the decimal place in the conversion factor [rollback]
  2. (diff | hist) 21:51 Fmoc chemistry 4,618 ±0 SPPS_Sorrel (talk | contribs) expand §Why the scheme matters downstream [rollback]
  3. (diff | hist) 21:23 Retention time 4,104 ±0 Chromatokid (talk | contribs) add the sample preparation, since the result depends on it [rollback]
  4. (diff | hist) 11:43 Reconstitution of lyophilised peptides 5,761 ±0 FmocFrancis (talk | contribs) add the sharps-disposal cross-link [rollback]
  5. (diff | hist) 11:07 Beyond-use date 23,108 +969 BlindSampleBrid (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  6. (diff | hist) 08:02 Prior authorisation 4,216 ±0 PriorAuthPaz (talk | contribs) rm a duplicated category [rollback]
  7. (diff | hist) m b 07:11 Customs seizure 4,785 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  8. (diff | hist) m 03:54 ISO 9001 4,278 ±0 ShortageShona (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  9. (diff | hist) m 00:50 Cost per milligram 4,125 ±0 IncretinIvo (talk | contribs) expand §Other axes that a price hides [rollback]
  10. (diff | hist) m 00:03 GenScript Peptides 12,070 +621 VerifyFirstVida (talk | contribs) unpipe a link that did not need piping [rollback]

14 December 2025

  1. (diff | hist) 22:45 Syringe dead space 15,689 +261 SubQ_Solveig (talk | contribs) expand §Measured and computed magnitudes [rollback]
  2. (diff | hist) m 22:39 Triple agonist 4,269 ±0 SemaglutideSasha (talk | contribs) attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]
  3. (diff | hist) 21:18 Reconstitution calculator 8,662 ±0 NPOV_Nadia (talk | contribs) add the reset control description [rollback]
  4. (diff | hist) 18:53 PolyPeptide Group (Hangzhou) 12,571 +913 ChainCustodyChad (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  5. (diff | hist) 11:09 Talk:Karl Fischer titration 1,307 +91 MergeMorwenna (talk | contribs) /* Merge proposal: Loss on drying into this article */ reply
  6. (diff | hist) 07:11 Dulaglutide 5,490 ±0 ArcuateArt (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  7. (diff | hist) m 04:14 Grey market 4,279 ±0 AnalyticalAnnie (talk | contribs) convert the storage conditions to a table [rollback]
  8. (diff | hist) 04:03 Receptor bias 4,477 ±0 BetaCellBoyd (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  9. (diff | hist) m b 01:42 Patent expiry and biosimilars 4,553 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) m 01:19 Fasting insulin 4,198 ±0 TSH_Tallulah (talk | contribs) state the assay the reference interval was established on [rollback]

13 December 2025

  1. (diff | hist) m 22:45 Liraglutide 5,967 ±0 INN_Ingrid (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  2. (diff | hist) m b 18:57 Missed dose 5,277 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) 16:32 Incretin effect 7,358 ±0 HyphenHarriet (talk | contribs) convert the receptor-distribution list to a table [rollback]
  4. (diff | hist) m 11:45 Dose escalation schedule 4,993 ±0 AnalyticalAnnie (talk | contribs) add the beyond-use interval with the storage condition it assumes [rollback]

12 December 2025

  1. (diff | hist) m b 23:55 SURMOUNT trial programme 5,021 ±0 CategoryBot (talk | contribs) bot: normalise trial registration identifier [rollback]
  2. (diff | hist) 23:06 Contraindications of incretin therapy 4,993 ±0 NAION_Noel (talk | contribs) add the interaction with the mechanism that explains it [rollback]
  3. (diff | hist) 20:07 Survodutide 5,445 ±0 ShortageShona (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  4. (diff | hist) m 19:17 Xi'an Mokemei Biotechnology 13,613 ±0 Chromatokid (talk | contribs) copyedit [rollback]
  5. (diff | hist) 15:44 Cold chain 27,150 +567 SupplyWatchSuri (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  6. (diff | hist) m 09:59 Counterfeit peptide 5,488 ±0 BlankVialBo (talk | contribs) close an unbalanced quotation mark [rollback]
  7. (diff | hist) m 09:41 Peptide synthesis 5,649 ±0 PrepHPLC_Pia (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  8. (diff | hist) 02:31 Vial 25,946 +480 CitationChaser (talk | contribs) add the cross-link to the temperature-excursion article [rollback]
  9. (diff | hist) 02:05 MOTS-c 4,670 ±0 ManualOfStyleMo (talk | contribs) de-duplicate a repeated sentence [rollback]

11 December 2025

  1. (diff | hist) m 23:22 Peptide aggregation 5,516 ±0 LeanMassLars (talk | contribs) add the plate-count expression and define its terms [rollback]
  2. (diff | hist) 22:42 Flourishglobal Peptide Biotech 13,174 +798 UnitsUrsula (talk | contribs) state what the certificate supplied with orders carries [rollback]
  3. (diff | hist) m 20:10 Chain of custody 5,157 ±0 CommaCarys (talk | contribs) add the retest interval and what triggers one [rollback]
  4. (diff | hist) 11:19 Talk:Xi'an Mokemei Biotechnology 1,244 +189 RfC_Rasmus (talk | contribs) /* Should the lot-identifier check be described on every supplier article? */ reply
  5. (diff | hist) m 08:00 Residual solvent 5,085 ±0 DiluentDiya (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]

10 December 2025

  1. (diff | hist) m b 23:30 Personal importation policy 4,121 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) m 18:18 C-peptide 4,400 ±0 BaselineBex (talk | contribs) add the paediatric interval with the caveat that it differs [rollback]
  3. (diff | hist) 10:24 AmbioPharm 9,826 +229 Peptide_Pete (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  4. (diff | hist) 09:23 Shenzhen Hybio Pharmaceutical 12,268 +136 GastroparesisGwen (talk | contribs) correct the other-designations row — those are trading variants, not subsidiaries [rollback]
  5. (diff | hist) 09:20 Talk:Albumin binding half-life extension 1,096 +96 ConsensusConal (talk | contribs) /* Should this be merged into the agonist article? */ reply
  6. (diff | hist) 07:33 Talk:Karl Fischer titration 1,096 +195 ParentCatPansy (talk | contribs) /* Merge proposal: Loss on drying into this article */ reply
  7. (diff | hist) 00:20 Dual incretin agonist 5,851 ±0 PurityClaimPia (talk | contribs) alphabetise the see-also list [rollback]

9 December 2025

  1. (diff | hist) 17:59 Third-party testing 7,489 ±0 SeeAlsoSelma (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  2. (diff | hist) 16:40 Talk:Karl Fischer titration 885 +221 EndotoxinEd (talk | contribs) /* Merge proposal: Loss on drying into this article */ reply
  3. (diff | hist) m 16:36 Medutest 5,018 ±0 IpamorelinIsold (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  4. (diff | hist) 13:22 Talk:Karl Fischer titration 674 +159 MergeMorwenna (talk | contribs) /* Merge proposal: Loss on drying into this article */ new section
  5. (diff | hist) 10:20 Bacterial endotoxin test 5,317 ±0 AnalyticalAnnie (talk | contribs) fix indentation in the source [rollback]
  6. (diff | hist) 10:08 Exenatide 5,754 ±0 MetricMabel (talk | contribs) add the structural figure and caption it properly [rollback]
  7. (diff | hist) 08:47 Talk:Temperature excursion 1,729 +189 HarmReductionHen (talk | contribs) /* Is a community-reported stability observation usable evidence at all? */ reply
  8. (diff | hist) 06:17 GL Biochem (Shanghai) 16,491 +220 FmocFrancis (talk | contribs) add the standing talk-page note link to the banner [rollback]
  9. (diff | hist) m b 06:07 Solid-phase peptide synthesis 5,359 ±0 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  10. (diff | hist) 04:09 Retatrutide 7,421 ±0 DulaglutideDug (talk | contribs) add the receptor targets to the lead sentence [rollback]
  11. (diff | hist) 03:38 GLP-1 receptor agonist 11,264 ±0 OrforglipronOona (talk | contribs) ce [rollback]

8 December 2025

  1. (diff | hist) 22:31 Global access disparity 4,391 ±0 ParentCatPansy (talk | contribs) add the cross-link to the insurance article [rollback]
  2. (diff | hist) m 20:21 Certificate of analysis 10,014 ±0 LedgerLysander (talk | contribs) rm the inference from one report to a supplier [rollback]
  3. (diff | hist) 20:01 Purity claim inflation 5,660 ±0 PurityClaimPia (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  4. (diff | hist) 13:33 Janoshik Analytical 5,235 ±0 PrimarySrcPatia (talk | contribs) add the retest interval and what triggers one [rollback]
  5. (diff | hist) 12:52 Contract development and manufacturing organisation 5,011 ±0 PrepHPLC_Pia (talk | contribs) give the closure integrity test by name [rollback]
  6. (diff | hist) m 12:45 Lot traceability 5,317 ±0 PrimarySrcPatia (talk | contribs) rm the aggregate pass-rate figure; the denominator is not knowable [rollback]
  7. (diff | hist) 10:20 Talk:Temperature excursion 1,518 +309 Chromatokid (talk | contribs) /* Is a community-reported stability observation usable evidence at all? */ reply
  8. (diff | hist) 02:35 GenScript Peptides 11,449 +1,111 AxisLabelAgda (talk | contribs) add the standing talk-page note link to the banner [rollback]

7 December 2025

  1. (diff | hist) m 21:29 Cold-chain freight 4,758 ±0 RepackRadek (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) m 16:37 Reverse-phase HPLC 5,499 ±0 AxisLabelAgda (talk | contribs) give the injection volume, without which the loading cannot be judged [rollback]
  3. (diff | hist) m 11:58 Guangzhou JEEP Biotechnology 15,232 ±0 UnitsUrsula (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  4. (diff | hist) 06:08 Lyophilisation 28,679 +558 SurvodutideSaff (talk | contribs) move a stray full stop inside the reference [rollback]

6 December 2025

  1. (diff | hist) 22:37 ChinaPeptides 14,759 ±0 GroupBuyGalen (talk | contribs) ce [rollback]
  2. (diff | hist) 22:30 Karl Fischer titration 9,318 ±0 MazdutideMads (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  3. (diff | hist) 18:50 Beta cell function 6,096 ±0 ProglucagonPia (talk | contribs) convert the receptor-distribution list to a table [rollback]
  4. (diff | hist) 18:24 Amylin receptor agonist 5,245 ±0 LipidLedgerLou (talk | contribs) add the discontinued indication with its date [rollback]
  5. (diff | hist) m b 15:03 Trifluoroacetate counterion 5,116 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) 13:49 Zhuhai Kerui Biotechnology 12,120 +1,074 ToneTilda (talk | contribs) add the catalogue size and label it self-reported [rollback]
  7. (diff | hist) m b 11:11 Melanotan II 4,649 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  8. (diff | hist) 08:36 Talk:Peptide stability table 1,170 +114 VerifyFirstVida (talk | contribs) /* Should extrapolated rows be in the table at all? */ reply
  9. (diff | hist) 07:23 Shanghai ERP Biotechnology 9,648 +363 HypoHildur (talk | contribs) rm the comparison with another supplier; there is no common basis for it [rollback]
  10. (diff | hist) m 05:44 Blind sampling 8,193 ±0 ColdChainCleo (talk | contribs) add short description [rollback]
  11. (diff | hist) m 03:09 Injection site rotation 4,872 ±0 NurseNoteNessa (talk | contribs) add category for preparation and handling [rollback]

5 December 2025

  1. (diff | hist) 16:22 SinoPep 13,439 +271 SecondarySrc_Seb (talk | contribs) rm the discount code added by an anonymous editor [rollback]
  2. (diff | hist) 13:55 Talk:Temperature excursion 1,307 +324 VerifyFirstVida (talk | contribs) /* Is a community-reported stability observation usable evidence at all? */ reply
  3. (diff | hist) 13:26 Number needed to treat 4,718 ±0 PioneerPerdita (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  4. (diff | hist) 09:31 Talk:Temperature excursion 1,096 +338 HarmReductionHen (talk | contribs) /* Is a community-reported stability observation usable evidence at all? */ reply
  5. (diff | hist) 09:28 Hubei Jianxiang Bioscience 13,286 +226 UnderfillUna (talk | contribs) unpipe a link that did not need piping [rollback]
  6. (diff | hist) 09:11 Talk:Peptide stability table 959 +95 ColdChainCleo (talk | contribs) /* Should extrapolated rows be in the table at all? */ reply
  7. (diff | hist) 06:53 Intention-to-treat analysis 4,963 ±0 INN_Ingrid (talk | contribs) add the confidence interval to the point estimate [rollback]
  8. (diff | hist) 06:36 Placebo-adjusted effect 4,805 ±0 Peptide_Pete (talk | contribs) correct the follow-up duration — the source gives weeks, we had months [rollback]
  9. (diff | hist) 02:36 SELECT trial 5,171 ±0 TrialsTabitha (talk | contribs) expand §Results and their interpretation [rollback]
  10. (diff | hist) 02:23 Peptide stability table 6,798 ±0 Retention_Time_Rae (talk | contribs) expand §Why cross-source comparison is unsafe [rollback]
  11. (diff | hist) 02:02 Temperature excursion 20,277 +585 CrudePeptidePearl (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]

4 December 2025

  1. (diff | hist) m 23:45 Bacteriostatic water 4,652 ±0 UnitsUrsula (talk | contribs) correct the label on the second column — that is volume, not mass [rollback]
  2. (diff | hist) 23:04 Oral semaglutide 4,582 ±0 SemaglutideSasha (talk | contribs) expand §Clinical position [rollback]
  3. (diff | hist) 15:08 Talk:Temperature excursion 885 +352 AnalyticalAnnie (talk | contribs) /* Is a community-reported stability observation usable evidence at all? */ reply
  4. (diff | hist) 15:02 Talk:Xi'an Mokemei Biotechnology 1,033 +282 BalanceBirdie (talk | contribs) /* Should the lot-identifier check be described on every supplier article? */ reply